PL352803A1 - Spliceosome protein and its use - Google Patents

Spliceosome protein and its use

Info

Publication number
PL352803A1
PL352803A1 PL00352803A PL35280300A PL352803A1 PL 352803 A1 PL352803 A1 PL 352803A1 PL 00352803 A PL00352803 A PL 00352803A PL 35280300 A PL35280300 A PL 35280300A PL 352803 A1 PL352803 A1 PL 352803A1
Authority
PL
Poland
Prior art keywords
spliceosome protein
spliceosome
protein
Prior art date
Application number
PL00352803A
Other languages
Polish (pl)
Inventor
Bettina Bauer
Reinhard Luhrmann
Cindy Will
Original Assignee
Aventis Research & Technologies Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Research & Technologies Gmbh & Co Kg filed Critical Aventis Research & Technologies Gmbh & Co Kg
Publication of PL352803A1 publication Critical patent/PL352803A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
PL00352803A 1999-06-04 2000-05-03 Spliceosome protein and its use PL352803A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19925668A DE19925668A1 (en) 1999-06-04 1999-06-04 Spliceosom protein and its use

Publications (1)

Publication Number Publication Date
PL352803A1 true PL352803A1 (en) 2003-09-08

Family

ID=7910274

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00352803A PL352803A1 (en) 1999-06-04 2000-05-03 Spliceosome protein and its use

Country Status (9)

Country Link
EP (1) EP1190049A1 (en)
JP (1) JP2003501085A (en)
AU (1) AU4915900A (en)
CA (1) CA2376055A1 (en)
DE (1) DE19925668A1 (en)
IL (1) IL146727A0 (en)
NO (1) NO20015906L (en)
PL (1) PL352803A1 (en)
WO (1) WO2000075309A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007031574B4 (en) 2007-07-06 2012-01-26 Karlsruher Institut für Technologie Minor spliceosome test system for modulating cell division

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5561222A (en) * 1989-11-15 1996-10-01 Duke University RNA-binding proteins useful for the control of cellular genetic processing and expression

Also Published As

Publication number Publication date
IL146727A0 (en) 2002-07-25
WO2000075309A1 (en) 2000-12-14
AU4915900A (en) 2000-12-28
NO20015906D0 (en) 2001-12-03
JP2003501085A (en) 2003-01-14
CA2376055A1 (en) 2000-12-14
DE19925668A1 (en) 2001-03-15
NO20015906L (en) 2002-02-04
EP1190049A1 (en) 2002-03-27

Similar Documents

Publication Publication Date Title
HRP20060251B1 (en) Substituted oxasolidinones and their use
IL149374A0 (en) New use and novel n-azabicyclo-amide derivatives
HUP0203430A3 (en) Quinazolinones and their use
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
HUP0103636A3 (en) 2-methyl-thieno-benzodiazepine formulation and its use
HU0001396D0 (en) 3-amino-3-arylpropan-1-al derivatives and their use
EP1210084A4 (en) Pyridomorphinans, thienomoprhinans and use thereof
GB0023323D0 (en) Arylhydantoin derivatives and uses thereof
EP1194147A4 (en) Arylthiazolidinedione and aryloxazolidinedione derivatives
EG22491A (en) Rest-breaking composition and use thereof
IL131719A0 (en) Iren protein its preparation and use
HUP0104723A3 (en) New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
EP1241256A4 (en) Novel gene and use thereof
IL145711A0 (en) Thrombospondin-2 and uses thereof
AU2669201A (en) Taccalonolides and their use
GB9807586D0 (en) Enzymes and their use
IL146727A0 (en) Spliceosome protein and its use
GB9929581D0 (en) Comjpositions and their use
IL146940A0 (en) Novel calpains and their use
GB9911606D0 (en) Composition and use
IL145152A0 (en) Novel protein and its use
HUP0105189A3 (en) Organoprotective solutions and their use
EP1227149A4 (en) Novel protein and use thereof
GB9916675D0 (en) Enigma-sip and enigma-cell
GB9908171D0 (en) Gene and use thereof